Chesterfield, MO, United States of America

Matt LaConte

This inventor holds 2 USPTO granted patents. Top assignee: Xrv-IP, LLC. Active years: 2020-2023.


% Patents Active = 100.0

Average Co-Inventor Count = 2.0

ph-index = 1


Company Filing History:


Years Active: 2020-2023

Loading Chart...
2 patents (USPTO):Explore Patents

Title: Innovations by Matt LaConte in Ophthalmic Surgical Instruments

Introduction

Matt LaConte is an accomplished inventor based in Chesterfield, MO (US). He has made significant contributions to the field of ophthalmic surgical instruments, holding a total of 2 patents. His innovative designs aim to enhance surgical procedures and improve patient outcomes.

Latest Patents

LaConte's latest patents focus on a probe tip assembly that incorporates an optical fiber for channeling light energy. The first patent describes a straightening tube that circumscribes the optical fiber and is moveable between two positions. This design allows for a guiding member that transitions between a straightened state and a pre-formed curved state, facilitating more precise surgical maneuvers. The second patent also features a similar probe tip assembly, but with a different metallic material for the straightening tube. This guiding member includes notches that enable the transition from a straightened state to a pre-formed curved state, enhancing the functionality of the instrument.

Career Highlights

LaConte is currently associated with Xrv-IP, LLC, where he continues to develop innovative solutions in the medical field. His work has garnered attention for its potential to revolutionize surgical techniques and improve the efficiency of ophthalmic procedures.

Collaborations

LaConte collaborates with James C Easley, leveraging their combined expertise to push the boundaries of innovation in their field.

Conclusion

Matt LaConte's contributions to ophthalmic surgical instruments exemplify the impact of innovation in medicine. His patents reflect a commitment to improving surgical practices and patient care.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to [email protected]
Loading…